Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
Lopez-Rodriguez, Rosario; Perez-Pampin, Eva; Marquez, Ana; Blanco, Francisco J; Joven, Beatriz; Carreira, Patricia; Ferrer, Miguel Angel; Caliz, Rafael; Valor, Lara; Narvaez, Javier; Cañete, Juan D; Ordoñez, Maria Del Carmen; Manrique-Arija, Sara; Vasilopoulos, Yiannis; Balsa, Alejandro; Pascual-Salcedo, Dora; Moreno-Ramos, Manuel J; Alegre-Sancho, Juan Jose; Navarro-Sarabia, Federico; Moreira, Virginia; Garcia-Portales, Rosa; Raya, Enrique; Magro-Checa, Cesar; Martin, Javier; Gomez-Reino, Juan J; Gonzalez, Antonio.
; 13(5): e0196793, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29734345
Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.
Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response.
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.
Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response.
Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome.
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.
Does a family history of RA influence the clinical presentation and treatment response in RA?